Cargando…

Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY(3-36) Combination Therapy in Diet-Induced Obese Rats

BACKGROUND: Combination therapies of anorectic gut hormones partially mimic the beneficial effects of bariatric surgery. Thus far, the effects of a combined chronic systemic administration of Glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine 3-36 (PYY(3-36)) have not been directly compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dischinger, Ulrich, Hasinger, Julia, Königsrainer, Malina, Corteville, Carolin, Otto, Christoph, Fassnacht, Martin, Hankir, Mohamed, Seyfried, Florian Johannes David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862770/ https://www.ncbi.nlm.nih.gov/pubmed/33551994 http://dx.doi.org/10.3389/fendo.2020.598843

Ejemplares similares

Liraglutide + PYY(3-36) Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
por: Metzner, Valentin, et al.
Publicado: (2022)

Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021)

Leptin Receptors Are Not Required for Roux-en-Y Gastric Bypass Surgery to Normalize Energy and Glucose Homeostasis in Rats
por: Hankir, Mohammed K., et al.
Publicado: (2021)

Do Bariatric Surgeries Enhance Brown/Beige Adipose Tissue Thermogenesis?
por: Hankir, Mohammed K., et al.
Publicado: (2020)

Effects of 2 Novel PYY(1-36) Analogues, (P(3)L(31)P(34))PYY(1-36) and PYY(1-36)(Lys(12)PAL), on Pancreatic Beta-Cell Function, Growth, and Survival
por: Lafferty, Ryan A, et al.
Publicado: (2019)

Salivary PYY: A Putative Bypass to Satiety
por: Acosta, Andres, et al.
Publicado: (2011)

Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR
por: Hankir, Mohammed K., et al.
Publicado: (2020)

Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study
por: Detomas, Mario, et al.
Publicado: (2022)

The PYY/Y2R-Deficient Mouse Responds Normally to High-Fat Diet and Gastric Bypass Surgery
por: Boland, Brandon, et al.
Publicado: (2019)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

Management of Patients With Glucocorticoid-Related Diseases and COVID-19
por: Chifu, Irina, et al.
Publicado: (2021)

PYY(3–36) and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
por: Field, Benjamin C.T., et al.
Publicado: (2010)

Gastric bypass surgery weight loss-independently induces gut Il-22 release in association with improved glycemic control in obese Zucker fatty rats
por: Seyfried, Florian, et al.
Publicado: (2022)

Leaky Gut as a Potential Culprit for the Paradoxical Dysglycemic Response to Gastric Bypass-Associated Ileal Microbiota
por: Hankir, Mohammed K., et al.
Publicado: (2021)

SAT-607 The Vagus Nerve and the Hypothalamus Mediate Different Aspects of the Anorectic Effects of PYY(3-36)
por: Alonso, Aldara Martin, et al.
Publicado: (2020)

The effect of fatty diacid acylation of human PYY(3-36) on Y(2) receptor potency and half-life in minipigs
por: Østergaard, Søren, et al.
Publicado: (2021)

The Gut Hormones PYY(3-36) and GLP-1(7-36 amide) Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans
por: De Silva, Akila, et al.
Publicado: (2011)

Gut Microbiota Contribution to Weight-Independent Glycemic Improvements after Gastric Bypass Surgery
por: Hankir, Mohammed K., et al.
Publicado: (2023)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
por: Caputo, Marina, et al.
Publicado: (2021)

Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment
por: Ivić, Vedrana, et al.
Publicado: (2023)

Acipimox Administration With Exercise Induces a Co-feedback Action of the GH, PP, and PYY on Ghrelin Associated With a Reduction of Peripheral Lipolysis in Bulimic and Healthy-Weight Czech Women: A Randomized Study
por: Smitka, Kvido, et al.
Publicado: (2019)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY
por: Guida, Claudia, et al.
Publicado: (2017)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes
por: Wu, Hao, et al.
Publicado: (2023)

Could de-stressing the brain be the solution for long-term weight loss?
por: Seyfried, Florian, et al.
Publicado: (2019)

Successful management of therapy-refractory pseudoachalasia after Ivor Lewis esophagectomy by bypassing colonic pull-up: A case report
por: Flemming, Sven, et al.
Publicado: (2021)

A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report
por: Wu, Shengjie, et al.
Publicado: (2021)

Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
por: El-Shafey, Mohamed, et al.
Publicado: (2022)

Satiety, but not total PYY, is increased with continuous and intermittent exercise
por: Holmstrup, ME, et al.
Publicado: (2013)

PYY is a negative regulator of bone mass and strength
por: Leitch, Victoria D., et al.
Publicado: (2019)

PYY, a Therapeutic Option for Type 2 Diabetes?
por: Guida, Claudia, et al.
Publicado: (2020)

Pancreatic PYY but not PPY expression is responsive to short-term nutritional state and the pancreas constitutes the major site of PYY mRNA expression in chickens
por: Reid, Angus M.A., et al.
Publicado: (2017)

Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue
por: Oliveira, Fernanda C. B., et al.
Publicado: (2022)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Elevated Interleukin-36α And CD4(+)IL-36α(+)T Cells Are Involved in the Pathogenesis of Graves' Disease
por: Yao, Qiu-ming, et al.
Publicado: (2018)

Self-Assembly of Lipopeptides Containing Short Peptide Fragments Derived from the Gastrointestinal Hormone PYY(3–36): From Micelles to Amyloid Fibrils
por: Hutchinson, Jessica A., et al.
Publicado: (2019)

Feeding a Modified Fish Diet to Bottlenose Dolphins Leads to an Increase in Serum Adiponectin and Sphingolipids
por: Sobolesky, Philip M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2rdeghijeurn2op8fv4q1pbuur